Suchergebnisse - "Lommatzsch, Marek"

PubPharm (186)

71

Impact of an increase in the inhaled corticosteroid dose on blood eosinophils in asthma

enthalten in: Thorax | 2019

von Lommatzsch, M. | Klein, M. | Stoll, P. | +1

72

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma : 1-year results from the BORA phase 3 extension trial

enthalten in: The Lancet. Respiratory medicine | 2019

von Busse, W. | Bleecker, E. | FitzGerald, J. | +107

CommentIn: Lancet Respir Med. 2019 Jan;7(1):5-6. - PMID 30416084

73

Patient Satisfaction and Clinical Outcomes with Budesonide plus Formoterol Spiromax for Asthma and Chronic Obstructive Pulmonary Disease : A Real-World, Observational Trial

enthalten in: Respiration; international review of thoracic diseases | 2019

von Gillissen, A. | Gessner, C. | Hechenbichler, K. | +7

74

Neoadjuvant PD-1 Blockade in Resectable Lung Cancer

enthalten in: The New England journal of medicine | 2018

von Lommatzsch, M. | Bratke, K. | Stoll, P.

CommentOn: N Engl J Med. 2018 May 24;378(21):1976-1986. - PMID 29658848

75

Current Asthma Treatment in Light of New Asthma Guidelines

enthalten in: Deutsche medizinische Wochenschrift (1946) | 2018

von Lommatzsch, M.

76

Moderne Asthma-Therapie im Licht der neuen Leitlinien

enthalten in: Deutsche medizinische Wochenschrift | 2018

von Lommatzsch, M.

77

Response to "obesity paradox in chronic obstructive pulmonary disease : A result of airflow obstruction over-grading?"

enthalten in: Respiratory medicine | 2017

von Lommatzsch, M. | Stoll, P.

CommentOn: Respir Med. 2016 Jul;116:59-62. - PMID 27296822

78

Addressing unmet needs in understanding asthma mechanisms : From the European Asthma Research and Innovation Partnership (EARIP) Work Package (WP)2 collaborators

enthalten in: The European respiratory journal | 2017

von Edwards, M. | Saglani, S. | Schwarze, J. | +22

79

Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA) : a randomised, double-blind, placebo-controlled phase 3 trial

enthalten in: Lancet (London, England) | 2016

von FitzGerald, J. | Bleecker, E. | Nair, P. | +12

CommentIn: Lancet. 2016 Oct 29;388(10056):2059-2060. - PMID 27609409

80

Bronchoalveolar lavage for the diagnosis of Pulmonary Langerhans cell histiocytosis

enthalten in: Respiratory medicine | 2016

von Lommatzsch, M. | Bratke, K. | Stoll, P. | +4